Serial Number | 90890805 |
Word Mark | ATOMIC AI |
Filing Date | Thursday, August 19, 2021 |
Status | 654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED |
Status Date | Monday, January 29, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | pharmaceutical preparations for the modification of RNA expression and alteration of RNA translation for the treatment of cancers and autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders, blood disorders, bone growth disorders, skin disorders, arthritis, hypertension, pain, stroke, obesity and diabetes |
Disclaimer with Predetermined Text | "AI" |
Goods and Services | research and development of pharmaceuticals, namely, therapies for the modification of RNA expression and alteration of RNA translation, used in the treatment of cancers and autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders, blood disorders, bone growth disorders, skin disorders, arthritis, hypertension, pain, stroke, obesity and diabetes; research and development in the fields of biotechnology, DNA, RNA, molecules and proteins; automated design and development of biomolecules for medical and scientific use, for use in the manufacture of biosensors, agriculture, synthetic biological research, laboratories and environmental safety and testing; drug design and development featuring machine-learning algorithms and lab automation tools; developing customized software in the field of drug design and development |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, October 6, 2021 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, October 6, 2021 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | ATOMATAI, INC. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Menlo Park, CA 94025 |
Event Date | Event Description |
Monday, January 29, 2024 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
Monday, July 31, 2023 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
Tuesday, January 31, 2023 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Tuesday, January 31, 2023 | LETTER OF SUSPENSION E-MAILED |
Tuesday, January 31, 2023 | SUSPENSION LETTER WRITTEN |
Saturday, January 14, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, January 13, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, January 13, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, January 9, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, January 9, 2023 | NON-FINAL ACTION E-MAILED |
Monday, January 9, 2023 | NON-FINAL ACTION WRITTEN |
Thursday, November 17, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, November 16, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, November 16, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, May 24, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, May 24, 2022 | NON-FINAL ACTION E-MAILED |
Tuesday, May 24, 2022 | NON-FINAL ACTION WRITTEN |
Monday, May 23, 2022 | ASSIGNED TO EXAMINER |
Wednesday, October 6, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Monday, August 23, 2021 | NEW APPLICATION ENTERED |